Gut Microbiota Regulates Brain–Bone Axis to Influence Osteoporosis Pathogenesis and Treatment
Research · 01.01.2026 · 9
DOI: 10.34133/research.1178 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Research, online erschienen am 16.03.2026. Verfasst von Haojun Shi und 11 weiteren Autor:innen. Beteiligte Einrichtung: Faculty of Chinese Medicine and State Key Laboratory of Quality Research in Chinese Medicines, Macau University of Science and Technology, Macau, Mac…. Die Arbeit wurde bisher 21-mal zitiert (Crossref) und nennt 97 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: National Natural Science Foundation of China, Science and Technology Development Fund, Macau SAR, High Level Key Discipline Construction Project of the State Administration of Traditional Chinese Medicine.
Abstract (Originalsprache)
Osteoporosis is a systemic skeletal disorder characterized by reduced bone mass, impaired microarchitecture, and increased fracture risk, primarily resulting from dysregulated bone remodeling. Increasing evidence highlights a close interaction between bone metabolism and the gut microbiota. Alterations in bone mineral density can influence gut microbial composition. Conversely, microbial dysbiosis disrupts bone homeostasis through multiple pathways, including microbial metabolites, immune regulation, and neuroendocrine signaling. Short-chain fatty acids suppress osteoclast differentiation and enhance intestinal calcium absorption, while gut dysbiosis promotes bone loss by impairing intestinal barrier integrity and increasing proinflammatory cytokines such as tumor necrosis factor-α and interleukin-6. The gut–brain–bone axis represents an important regulatory network linking the central nervous system, gut-derived signals, and skeletal remodeling. Chronic stress and neurodegenerative conditions activate the hypothalamic–pituitary–adrenal axis and bone-derived extracellular vesicle signaling, thereby favoring bone resorption. Estrogen deficiency further disrupts the receptor activator of nuclear factor κΒ ligand/osteoprotegerin signaling pathway and alters gut microbial composition, contributing to postmenopausal bone loss. Therapeutic strategies targeting this axis, including probiotics, prebiotics, fecal microbiota transplantation, dietary fiber supplementation, and pharmacological or natural compounds, show potential in restoring microbial balance and improving bone metabolism. Future studies integrating multiomics approaches and well-designed clinical trials are needed to clarify microbiome–bone interactions and support the development of targeted interventions for osteoporosis.
Autor:innen und Institutionen
- Faculty of Chinese Medicine and State Key Laboratory of Quality Research in Chinese Medicines, Macau University of Science and Technology, Macau, Macau SAR, China.
- Department of Molecular Cell and Cancer Biology, University of Massachusetts Chan Medical School, Lake Avenue North, Worcester, MA 01605, USA.
- Department of Neurosurgery, Department of Physiology and Pharmacology, Department of Neurosurgery and Anesthesiology, School of Medicine, Loma Linda University, Risley Hall, Room 219, 11041 Campus Street, Loma Linda, CA…
- Fujian Key Laboratory of Toxicant and Drug Toxicology, Medical College, Ningde Normal University, Ningde, China.
- Science and Technology Innovation Center, Shandong First Medical University & Shandong Academy of Medical Science, Jinan, China.
- School of Traditional Chinese Medicine, Shandong First Medical University & Shandong Academy of Medical Science, Jinan, China.
ORCID-Profile: Yisheng Chen
Förderung
- National Natural Science Foundation of China
- Science and Technology Development Fund, Macau SAR
- High Level Key Discipline Construction Project of the State Administration of Traditional Chinese Medicine
- Integration Development Strategy Project of Jinan City and College
- clinical-basic joint innovation team project of Shandong First Medical University
- Natural Science Foundation of Shandong Province
- University Youth Innovation Team of Shandong Province
- Young Talent of Lifting engineering for Science and Technology in Shandong
Zitieren
APA
Shi, H., Huang, L., Zhang, J. H., Shen, C., Zhang, N., Lv, C., Shao, L., Li, M., Sun, Z., Shi, L., Yu, G., & Chen, Y. (2026). Gut Microbiota Regulates Brain–Bone Axis to Influence Osteoporosis Pathogenesis and Treatment. Research, 9. https://doi.org/10.34133/research.1178
Vancouver
Shi H, Huang L, Zhang JH, Shen C, Zhang N, Lv C, et al. Gut Microbiota Regulates Brain–Bone Axis to Influence Osteoporosis Pathogenesis and Treatment. Research. 2026;9. doi:10.34133/research.1178
BibTeX
@article{Shi2026,
author = {Shi, Haojun and Huang, Lei and Zhang, John H and Shen, Chengwan and Zhang, Nan and Lv, Cui and Shao, Litao and Li, Mengyao and Sun, Zijin and Shi, Liang and Yu, Gongchang and Chen, Yisheng},
title = {Gut Microbiota Regulates Brain–Bone Axis to Influence Osteoporosis Pathogenesis and Treatment},
journal = {Research},
year = {2026},
volume = {9},
doi = {10.34133/research.1178}
}
EUVIMED